Daniel Faga - 01 Nov 2026 Form 4 Insider Report for First Tracks Biotherapeutics, Inc. (TRAX)

Reporting relationship: President, CEO, Director
Issuer ticker: TRAX
Reported as of: 01 Nov 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Nov 2026, 18:01:33 UTC
Prior SEC filing: 18 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Ajim Tamboli, Attorney-in-Fact

Filing notes and source

Key filing fact

Daniel Faga filed Form 4 for First Tracks Biotherapeutics, Inc. (TRAX) on 03 Nov 2026.

Key facts

This page summarizes Daniel Faga's Form 4 filing for First Tracks Biotherapeutics, Inc. (TRAX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Nov 2026, 18:01.

Change

Previous filing in this sequence was filed on 18 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001673528 Primary reporting owner

Faga Daniel

Relationship: President, CEO, Director
Address: 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature: /s/ Ajim Tamboli, Attorney-in-Fact
Signature date: 03 Nov 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRAX transaction Derivative

Common Stock

Award

Transaction value
Shares: +136,000
Change %
Price: $0.000000^*
Shares after: 136,000
Date: 01 Nov 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 136,000
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on November 1, 2026. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics ("Performance Metrics"). Once an applicable Performance Metric has been met, the PSUs subject to such Performance Metric (an "Achieved PSU") shall vest as follows: 50% of the Achieved PSUs for each satisfied tranche shall vest on the one-year anniversary of the Certification Date of the achievement of the applicable Performance Metric, and the remaining 50% of the Achieved PSUs shall vest on the two-year anniversary of the applicable Certification Date.

Footnote F3

(cont'd from Footnote 2) Notwithstanding the foregoing, all Achieved PSUs that have not previously vested pursuant to the vesting schedule will vest on December 15, 2030 (or, if a Share Price Target is achieved on December 15, 2030, vesting will occur on its Certification Date), subject to the Reporting Person's service to the Issue on each vesting date.